|
1
|
Ostermann M, Lumlertgul N, Jeong R, See E,
Joannidis M and James M: Acute kidney injury. Lancet. 405:241–256.
2025.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Scholz H, Boivin FJ, Schmidt-Ott KM,
Bachmann S, Eckardt KU, Scholl UI and Persson PB: Kidney physiology
and susceptibility to acute kidney injury: Implications for
renoprotection. Nat Rev Nephrol. 17:335–349. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Susantitaphong P, Cruz DN, Cerda J,
Abulfaraj M, Alqahtani F, Koulouridis I and Jaber BL: Acute Kidney
Injury Advisory Group of the American Society of Nephrology. World
incidence of AKI: A meta-Analysis. Clin J Am Soc Nephro.
8:1482–1493. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Motwani SS, Kaur SS and Kitchlu A:
Cisplatin nephrotoxicity: Novel insights into mechanisms and
preventative strategies. Semin Nephrol. 42(151341)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ambe K, Aoki Y, Murashima M, Wachino C,
Deki Y, Ieda M, Kondo M, Furukawa-Hibi Y, Kimura K, Hamano T and
Tohkin M: Prediction of cisplatin-induced acute kidney injury using
an interpretable machine learning model and electronic medical
record information. Clin Transl Sci. 18(e70115)2025.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ghosh S: Cisplatin: The first metal based
anticancer drug. Bioorg Chem. 88(102925)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Fang CY, Lou DY, Zhou LQ, Wang JC, Yang B,
He QJ, Wang JJ and Weng QJ: Natural products: Potential treatments
for cisplatin-induced nephrotoxicity. Acta Pharmacol Sin.
42:1951–1969. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhang X, Chen W, Du Y, Su P, Qiu Y, Ning J
and Liu M: Phytochemistry and pharmacological activities of
Arundina graminifolia (D.Don) Hochr. And other common
Orchidaceae medicinal plants. J Ethnopharmacol.
276(114143)2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li J, Zhou L, Wang J, Zhang L, Xia B, Li
G, Ren J and Li J: Evaluation of the methanol extract of
BaiYangJie: Toxicology and protective effect against acute kidney
injury. J Adv Pharm Technol Res. 15:185–193. 2024.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Newgard CB: Metabolomics and metabolic
diseases: Where do we stand? Cell Metab. 25:43–56. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Cao H, Zhang A, Zhang H, Sun H and Wang X:
The application of metabolomics in traditional Chinese medicine
opens up a dialogue between Chinese and Western medicine. Phytother
Res. 29:159–166. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
National Research Council, Division on
Earth and Life Studies, Institute for Laboratory Animal Research,
Committee for the Update of the Guide for the Guide for the Care
and Use of Laboratory Animals: Eighth edition. Guide for the care
and use of laboratory animals. National Academies Press, 2011.
|
|
14
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The gene
ontology consortium. Nat Genet. 25:25–29. 2000.PubMed/NCBI View Article : Google Scholar
|
|
16
|
The Gene Ontology Consortium. The gene
ontology resource: 20 years and still GOing strong. Nucleic Acids
Res. 47 (D1):D330–D338. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tsugawa H, Cajka T, Kind T, Ma Y, Higgins
B, Ikeda K, Kanazawa M, VanderGheynst J, Fiehn O and Arita M:
MS-DIAL: Data-independent MS/MS deconvolution for comprehensive
metabolome analysis. Nat Methods. 12:523–526. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yan ZH, Li WS, Liang BY, et al: Comparison
of chemical constituents between Isatidis Radix and Isatidis Folium
based on UPLC-Q-TOF-MS/MS technology. Chin Tradit Herbal Drugs.
55:3956–3965. 2024.
|
|
19
|
Meng XW, Cai DJ, Zhu Q, et al: Rapid
identification of chemical constituents in Dalbergia
cochinchinensis heartwood based on UPLC-Q-TOF-MS/MS technology.
Chin J Exp Tradit Med Formula. 26:143–156. 2020.
|
|
20
|
Wang YC, Han B, Li ZJ, et al: Study on
chemical constituents of Dendrobium pendulum based on
UPLC-Q-TOF-MS. Chin Pharm J. 56:708–714. 2021.
|
|
21
|
Mou Y, Liu B, Zhang X, et al: Component
analysis and anti-inflammatory activity evaluation of different
parts of Forsythia suspensa based on UPLC-Q-TOF-MS. China J Chin
Mater Med. 49:968–980. 2024.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Huo JH, Sun GD, Wei WF, et al: Analysis of
chemical constituents in Niuhuang Qinggan Capsules by
UPLC-Q-TOF/MS. Chin Tradit Pat Med. 40:2340–2348. 2018.
|
|
23
|
Lei JC, Zhang ST, Hu XR, et al:
Investigation of the pharmacodynamic material basis and mechanism
of Jinbei Oral Liquid against idiopathic pulmonary fibrosis by
UHPLC-Q-TOF-MS/MS combined with network pharmacology. China J Chin
Mater Med. 1–16. 2025.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wu CH, Liu YY, Xing SP, et al: Screening
of potential anti-inflammatory active components of Gonglaomu based
on UPLC-Q-TOF-MS metabolomics technology. J Chin Med Mater.
48:389–395. 2025.
|
|
25
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Hayden MS, West AP and Ghosh S: NF-kappaB
and the immune response. Oncogene. 25:6758–6780. 2006.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhang Y, Tang PM, Niu Y, García Córdoba
CA, Huang XR, Yu C and Lan HY: Long non-coding RNA LRNA9884
promotes acute kidney injury via regulating NF-kB-mediated
transcriptional activation of MIF. Front Physiol.
11(590027)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chen J, Xu X, Cai Y, Zhang Q, Wang X and
Zhang D: Acute kidney injury over the past decade: From definition
evolution to pathogenesis insights and innovative therapeutic
strategies. Cell Mol Life Sci. 83(156)2026.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gao J, Deng Q, Yu J, Wang C and Wei W:
Role of renal tubular epithelial cells and macrophages in
cisplatin-induced acute renal injury. Life Sci. 339:122450.
2024.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Megyesi J, Safirstein RL and Price PM:
Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the
course of cisplatin-induced acute renal failure. J Clin Invest.
101:777–782. 1998.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Holditch SJ, Brown CN, Lombardi AM, Nguyen
KN and Edelstein CL: Recent advances in models, mechanisms,
biomarkers, and interventions in cisplatin-induced acute kidney
injury. Int J Mol Sci. 20(3011)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Salei N, Rambichler S, Salvermoser J,
Papaioannou NE, Schuchert R, Pakalniškytė D, Li N, Marschner JA,
Lichtnekert J, Stremmel C, et al: The kidney contains
ontogenetically distinct dendritic cell and macrophage subtypes
throughout development that differ in their inflammatory
properties. J Am Soc Nephrol. 31:257–278. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ramesh G and Reeves WB: TNF-alpha mediates
chemokine and cytokine expression and renal injury in cisplatin
nephrotoxicity. J Clin Invest. 110:835–842. 2002.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Pober JS: Endothelial activation:
Intracellular signaling pathways. Arthritis Res. 4 (Suppl
3):S109–S116. 2002.PubMed/NCBI View
Article : Google Scholar
|
|
35
|
Zhang J, Luan ZL, Huo XK, Zhang M,
Morisseau C, Sun CP, Hammock BD and Ma XC: Direct targeting of sEH
with alisol B alleviated the apoptosis, inflammation, and oxidative
stress in cisplatin-induced acute kidney injury. Int J Biol Sci.
19:294–310. 2023.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhou X, Jiang K, Luo H, Wu C, Yu W and
Cheng F: Novel lncRNA XLOC_032768 alleviates cisplatin-induced
apoptosis and inflammatory response of renal tubular epithelial
cells through TNF-α. Int Immunopharmacol. 83(106472)2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Qu X, Gao H, Sun J, Tao L, Zhang Y, Zhai
J, Song Y, Hu T and Li Z: Identification of key metabolites during
cisplatin-induced acute kidney injury using an HPLC-TOF/MS-based
non-targeted urine and kidney metabolomics approach in rats.
Toxicology. 431(152366)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Mahmod II, Ismail IS, Alitheen NB, Normi
YM, Abas F, Khatib A, Rudiyanto and Latip J: NMR and LCMS
analytical platforms exhibited the nephroprotective effect of
Clinacanthus nutans in cisplatin-induced nephrotoxicity in the in
vitro condition. BMC Complement Med Ther. 20(320)2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Sun J, Shannon M, Ando Y, Schnackenberg
LK, Khan NA, Portilla D and Beger RD: Serum metabolomic profiles
from patients with acute kidney injury: A pilot study. J Chromatogr
B Analyt Technol Biomed Life Sci. 893-894:107–113. 2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Huang SS, Lin JY, Chen WS, Liu MH, Cheng
CW, Cheng ML and Wang CH: Phenylalanine- and leucine-defined
metabolic types identify high mortality risk in patients with
severe infection. Int J Infect Dis. 85:143–149. 2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Song Y, Hu T, Gao H, Zhai J, Gong J, Zhang
Y, Tao L, Sun J, Li Z and Qu X: Altered metabolic profiles and
biomarkers associated with astragaloside IV-mediated protection
against cisplatin-induced acute kidney injury in rats: An
HPLC-TOF/MS-based untargeted metabolomics study. Biochem Pharmacol.
183(114299)2021.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Ashe K, Kelso W, Farrand S, Panetta J,
Fazio T, De Jong G and Walterfang M: Psychiatric and cognitive
aspects of phenylketonuria: The limitations of diet and promise of
new treatments. Front Psychiatry. 10(561)2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Zheng T, Su S, Dai X, Zhang L, Duan JA and
Ou-Yang Z: Metabolomic analysis of biochemical changes in the serum
and urine of freund's Adjuvant-Induced arthritis in rats after
treatment with silkworm excrement. Molecules.
23(1490)2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Tokuno M, Commey KL, Yamamoto A, Tokushige
M, Tsukigawa K, Nishi K, Otagiri M, Ekino K and Yamasaki K:
Insights into the renal protective effects of 7-phenylheptanoic
acid in chronic kidney disease mice: Modulation of indoxyl sulfate
production and gut microbiome homeostasis. Drug Metab Dispos.
53(100149)2025.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Wang SY and Nesheim MC: Kidney clearance
of D- and L-tryptophan by rats. Comp Biochem Physiol A Comp
Physiol. 85:451–453. 1986.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Gao J, Gu Z, Li M, Xu Y, Gao Y, Wei J,
Liang B and Na Y: L-carnitine ameliorates the decrease of aquaporin
2 levels in rats with cisplatin-induced kidney injury. Nephron.
135:315–325. 2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Chisty TTE, Sarif S, Jahan I, Ismail IN,
Chowdhury FI, Siddiqua S, Yasmin T, Islam MN, Khan F, Subhan N and
Alam MA: Protective effects of l-carnitine on isoprenaline-induced
heart and kidney dysfunctions: Modulation of inflammation and
oxidative stress-related gene expression in rats. Heliyon.
10(e25057)2024.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Li AS, Baker PR II, Park S, Budnick I, He
Z, Okamura K, Gil HW, Miyazaki M, Anderson CC, Reisz JA and Faubel
S: Metabolomic assessment reveals depletion of amino acids and
energy metabolites in skeletal muscle after ischemic acute kidney
injury in mice. Sci Rep. 16(8823)2026.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Okamoto K, Kitaichi F, Saito Y, Ueda H,
Narumi K, Furugen A and Kobayashi M: Antioxidant effect of ascorbic
acid against cisplatin-induced nephrotoxicity and P-glycoprotein
expression in rats. Eur J Pharmacol. 909(174395)2021.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Wei T, Liu B, Chen Y and Li C: Protective
effect of ascorbic acid against renal injury induced by
3-chloropropane-1,2-diol-dipalmitate in rats. Renal Fail.
46(2429694)2024.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Kim IY, Song SH, Seong EY, Lee DW, Bae SS
and Lee SB: Akt1 is involved in renal fibrosis and tubular
apoptosis in a murine model of acute kidney injury-to-chronic
kidney disease transition. Exp Cell Res. 424(113509)2023.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Lucas RM, Luo L and Stow JL: ERK1/2 in
immune signalling. Biochem Soc Trans. 50:1341–1352. 2022.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Capolongo G, Suzumoto Y, D'Acierno M,
Simeoni M, Capasso G and Zacchia M: ERK1,2 signalling pathway along
the nephron and its role in acid-base and electrolytes balance. Int
J Mol Sci. 20(4153)2019.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Poh AR, Love CG, Chisanga D, Steer JH,
Baloyan D, Chopin M, Nutt S, Rautela J, Huntington ND, Etemadi N,
et al: Therapeutic inhibition of the SRC-kinase HCK facilitates T
cell tumor infiltration and improves response to immunotherapy. Sci
Adv. 8(eabl7882)2022.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Sumaiya K, Langford D, Natarajaseenivasan
K and Shanmughapriya S: Macrophage migration inhibitory factor
(MIF): A multifaceted cytokine regulated by genetic and
physiological strategies. Pharmacol Ther.
233(108024)2022.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Bloom BR and Bennett B: Mechanism of a
reaction in vitro associated with delayed-type hypersensitivity.
Science. 153:80–82. 1966.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Lan HY: Role of macrophage migration
inhibition factor in kidney disease. Nephron Exp Nephrol.
109:e79–e83. 2008.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Kong YZ, Chen Q and Lan HY: Macrophage
migration inhibitory factor (MIF) as a stress molecule in renal
inflammation. Int J Mol Sci. 23(4908)2022.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Pohl J, Hendgen-Cotta UB, Stock P, Luedike
P and Rassaf T: Elevated MIF-2 levels predict mortality in
critically ill patients. J Crit Care. 40:52–57. 2017.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Hoffmann A: Immune response signaling:
Combinatorial and dynamic control. Trends Immunol. 37:570–572.
2016.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Liu H, Lo CR and Czaja MJ: NF-kappaB
inhibition sensitizes hepatocytes to TNF-induced apoptosis through
a sustained activation of JNK and c-Jun. Hepatology. 35:772–778.
2002.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Grivennikov S, Karin E, Terzic J, Mucida
D, Yu GY, Vallabhapurapu S, Scheller J, Rose-John S, Cheroutre H,
Eckmann L and Karin M: IL-6 and Stat3 are required for survival of
intestinal epithelial cells and development of colitis-associated
cancer. Cancer Cell. 15:103–113. 2009.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Zhang H and Sun SC: NF-κB in inflammation
and renal diseases. Cell Biosci. 5(63)2015.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Liu H, Xiong J, He T, Xiao T, Li Y, Yu Y,
Huang Y, Xu X, Huang Y, Zhang J, et al: High uric acid-induced
epithelial-mesenchymal transition of renal tubular epithelial cells
via the TLR4/NF-kB signaling pathway. Am J Nephrol. 46:333–342.
2017.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Zhang B, Zeng M, Wang Y, Li M, Wu Y, Xu R,
Zhang Q, Jia J, Huang Y, Zheng X and Feng W: Oleic acid alleviates
LPS-induced acute kidney injury by restraining inflammation and
oxidative stress via the Ras/MAPKs/PPAR-γ signaling pathway.
Phytomedicine. 94(153818)2022.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Hu JC, Song JY, Feng R, Ye ML, Xu H, Lu
JY, Zuo HT, Zhao Y, Wang JY, Jin JY, et al: Integrated gut
microbiota-drug interaction analysis and network pharmacology for
the investigation of renal-protective effect of Polygala tenuifolia
Willd. Int J Mol Sci. 26(10889)2025.PubMed/NCBI View Article : Google Scholar
|
